Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer

Clinical trial NCT01386346 · COMPLETED

Trial details

NCT number: NCT01386346
Sponsor: Weill Medical College of Cornell University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal Cancer Malignant Neoplasm of Cardio-esophageal Junction of Stomach

Start date: 2011-06-01
Primary completion: 2014-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.